IBDEI0CO ; ; 18-NOV-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;NOV 18, 2013
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16893,1,2,0)
 ;;=2^332.0
 ;;^UTILITY(U,$J,358.3,16893,1,5,0)
 ;;=5^Parkinsonism
 ;;^UTILITY(U,$J,358.3,16893,2)
 ;;=^304847
 ;;^UTILITY(U,$J,358.3,16894,0)
 ;;=333.79^^99^911^2
 ;;^UTILITY(U,$J,358.3,16894,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16894,1,2,0)
 ;;=2^333.79
 ;;^UTILITY(U,$J,358.3,16894,1,5,0)
 ;;=5^Acute Dystonia
 ;;^UTILITY(U,$J,358.3,16894,2)
 ;;=^334068
 ;;^UTILITY(U,$J,358.3,16895,0)
 ;;=333.85^^99^911^4
 ;;^UTILITY(U,$J,358.3,16895,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16895,1,2,0)
 ;;=2^333.85
 ;;^UTILITY(U,$J,358.3,16895,1,5,0)
 ;;=5^Tardive Dyskinesia
 ;;^UTILITY(U,$J,358.3,16895,2)
 ;;=^334069
 ;;^UTILITY(U,$J,358.3,16896,0)
 ;;=V87.39^^99^912^1
 ;;^UTILITY(U,$J,358.3,16896,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16896,1,2,0)
 ;;=2^V87.39
 ;;^UTILITY(U,$J,358.3,16896,1,5,0)
 ;;=5^Cont/Exp Hazard Sub NEC
 ;;^UTILITY(U,$J,358.3,16896,2)
 ;;=^336815
 ;;^UTILITY(U,$J,358.3,16897,0)
 ;;=310.0^^99^913^2
 ;;^UTILITY(U,$J,358.3,16897,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16897,1,2,0)
 ;;=2^310.0
 ;;^UTILITY(U,$J,358.3,16897,1,5,0)
 ;;=5^Frontal Lobe Syndrome
 ;;^UTILITY(U,$J,358.3,16897,2)
 ;;=^265201
 ;;^UTILITY(U,$J,358.3,16898,0)
 ;;=310.1^^99^913^3
 ;;^UTILITY(U,$J,358.3,16898,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16898,1,2,0)
 ;;=2^310.1
 ;;^UTILITY(U,$J,358.3,16898,1,5,0)
 ;;=5^Personality Chg d/t TBI/Lesion
 ;;^UTILITY(U,$J,358.3,16898,2)
 ;;=^331953
 ;;^UTILITY(U,$J,358.3,16899,0)
 ;;=310.2^^99^913^4
 ;;^UTILITY(U,$J,358.3,16899,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16899,1,2,0)
 ;;=2^310.2
 ;;^UTILITY(U,$J,358.3,16899,1,5,0)
 ;;=5^Postconcussion Syndrome
 ;;^UTILITY(U,$J,358.3,16899,2)
 ;;=^265160
 ;;^UTILITY(U,$J,358.3,16900,0)
 ;;=310.81^^99^913^5
 ;;^UTILITY(U,$J,358.3,16900,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16900,1,2,0)
 ;;=2^310.81
 ;;^UTILITY(U,$J,358.3,16900,1,5,0)
 ;;=5^Pseudobulbar Affect
 ;;^UTILITY(U,$J,358.3,16900,2)
 ;;=^340506
 ;;^UTILITY(U,$J,358.3,16901,0)
 ;;=310.89^^99^913^1
 ;;^UTILITY(U,$J,358.3,16901,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16901,1,2,0)
 ;;=2^310.89
 ;;^UTILITY(U,$J,358.3,16901,1,5,0)
 ;;=5^Brain Damage D/O,Oth Spec
 ;;^UTILITY(U,$J,358.3,16901,2)
 ;;=^268320
 ;;^UTILITY(U,$J,358.3,16902,0)
 ;;=90833^^100^914^1^^^^1
 ;;^UTILITY(U,$J,358.3,16902,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16902,1,2,0)
 ;;=2^90833
 ;;^UTILITY(U,$J,358.3,16902,1,3,0)
 ;;=3^Psytx 16-37 min;Report w/ E&M
 ;;^UTILITY(U,$J,358.3,16903,0)
 ;;=90836^^100^914^2^^^^1
 ;;^UTILITY(U,$J,358.3,16903,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16903,1,2,0)
 ;;=2^90836
 ;;^UTILITY(U,$J,358.3,16903,1,3,0)
 ;;=3^Psytx 38-52 min;Report w/ E&M
 ;;^UTILITY(U,$J,358.3,16904,0)
 ;;=90838^^100^914^3^^^^1
 ;;^UTILITY(U,$J,358.3,16904,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16904,1,2,0)
 ;;=2^90838
 ;;^UTILITY(U,$J,358.3,16904,1,3,0)
 ;;=3^Psytx >52 min;Report w/ E&M
 ;;^UTILITY(U,$J,358.3,16905,0)
 ;;=90853^^100^915^4^^^^1
 ;;^UTILITY(U,$J,358.3,16905,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16905,1,2,0)
 ;;=2^90853
 ;;^UTILITY(U,$J,358.3,16905,1,3,0)
 ;;=3^Group Psychotherapy
 ;;^UTILITY(U,$J,358.3,16906,0)
 ;;=90846^^100^915^5^^^^1
 ;;^UTILITY(U,$J,358.3,16906,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16906,1,2,0)
 ;;=2^90846
 ;;^UTILITY(U,$J,358.3,16906,1,3,0)
 ;;=3^Family Psychotherapy w/o pt.
 ;;^UTILITY(U,$J,358.3,16907,0)
 ;;=90847^^100^915^6^^^^1
 ;;^UTILITY(U,$J,358.3,16907,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16907,1,2,0)
 ;;=2^90847
 ;;^UTILITY(U,$J,358.3,16907,1,3,0)
 ;;=3^Family Psychotherpy w/pt.
 ;;^UTILITY(U,$J,358.3,16908,0)
 ;;=90875^^100^915^7^^^^1
 ;;^UTILITY(U,$J,358.3,16908,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16908,1,2,0)
 ;;=2^90875
 ;;^UTILITY(U,$J,358.3,16908,1,3,0)
 ;;=3^with Biofeedback, 20-30 min
 ;;^UTILITY(U,$J,358.3,16909,0)
 ;;=90876^^100^915^8^^^^1
 ;;^UTILITY(U,$J,358.3,16909,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16909,1,2,0)
 ;;=2^90876
 ;;^UTILITY(U,$J,358.3,16909,1,3,0)
 ;;=3^with Biofeedback, 45-50 min
 ;;^UTILITY(U,$J,358.3,16910,0)
 ;;=90832^^100^915^1^^^^1
 ;;^UTILITY(U,$J,358.3,16910,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16910,1,2,0)
 ;;=2^90832
 ;;^UTILITY(U,$J,358.3,16910,1,3,0)
 ;;=3^Psychotherapy 16-37 min
 ;;^UTILITY(U,$J,358.3,16911,0)
 ;;=90834^^100^915^2^^^^1
 ;;^UTILITY(U,$J,358.3,16911,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16911,1,2,0)
 ;;=2^90834
 ;;^UTILITY(U,$J,358.3,16911,1,3,0)
 ;;=3^Psychotherapy 38-52 min
 ;;^UTILITY(U,$J,358.3,16912,0)
 ;;=90837^^100^915^3^^^^1
 ;;^UTILITY(U,$J,358.3,16912,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16912,1,2,0)
 ;;=2^90837
 ;;^UTILITY(U,$J,358.3,16912,1,3,0)
 ;;=3^Psychotherapy 53+ min
 ;;^UTILITY(U,$J,358.3,16913,0)
 ;;=90899^^100^916^10^^^^1
 ;;^UTILITY(U,$J,358.3,16913,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16913,1,2,0)
 ;;=2^90899
 ;;^UTILITY(U,$J,358.3,16913,1,3,0)
 ;;=3^NOS Psych Service
 ;;^UTILITY(U,$J,358.3,16914,0)
 ;;=J1631^^100^916^6^^^^1
 ;;^UTILITY(U,$J,358.3,16914,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16914,1,2,0)
 ;;=2^J1631
 ;;^UTILITY(U,$J,358.3,16914,1,3,0)
 ;;=3^Haldol, per 50 mg
 ;;^UTILITY(U,$J,358.3,16915,0)
 ;;=J2680^^100^916^16^^^^1
 ;;^UTILITY(U,$J,358.3,16915,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16915,1,2,0)
 ;;=2^J2680
 ;;^UTILITY(U,$J,358.3,16915,1,3,0)
 ;;=3^Prolixin, per 25mg
 ;;^UTILITY(U,$J,358.3,16916,0)
 ;;=97545^^100^916^29^^^^1
 ;;^UTILITY(U,$J,358.3,16916,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16916,1,2,0)
 ;;=2^97545
 ;;^UTILITY(U,$J,358.3,16916,1,3,0)
 ;;=3^Work Therapy, Init 2 hrs
 ;;^UTILITY(U,$J,358.3,16917,0)
 ;;=97546^^100^916^28^^^^1
 ;;^UTILITY(U,$J,358.3,16917,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16917,1,2,0)
 ;;=2^97546
 ;;^UTILITY(U,$J,358.3,16917,1,3,0)
 ;;=3^Work Ther, addl hrs after 2
 ;;^UTILITY(U,$J,358.3,16918,0)
 ;;=97537^^100^916^3^^^^1
 ;;^UTILITY(U,$J,358.3,16918,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16918,1,2,0)
 ;;=2^97537
 ;;^UTILITY(U,$J,358.3,16918,1,3,0)
 ;;=3^Community/Work Reintegration per 15 min
 ;;^UTILITY(U,$J,358.3,16919,0)
 ;;=97532^^100^916^2^^^^1
 ;;^UTILITY(U,$J,358.3,16919,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16919,1,2,0)
 ;;=2^97532
 ;;^UTILITY(U,$J,358.3,16919,1,3,0)
 ;;=3^Cognitive Sk Dev (PhD/OT)per 15min
 ;;^UTILITY(U,$J,358.3,16920,0)
 ;;=97533^^100^916^22^^^^1
 ;;^UTILITY(U,$J,358.3,16920,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16920,1,2,0)
 ;;=2^97533
 ;;^UTILITY(U,$J,358.3,16920,1,3,0)
 ;;=3^Sensory Integrat per 15 min
 ;;^UTILITY(U,$J,358.3,16921,0)
 ;;=97535^^100^916^1^^^^1
 ;;^UTILITY(U,$J,358.3,16921,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16921,1,2,0)
 ;;=2^97535
 ;;^UTILITY(U,$J,358.3,16921,1,3,0)
 ;;=3^ADL Train per 15 min
 ;;^UTILITY(U,$J,358.3,16922,0)
 ;;=H0004^^100^916^8^^^^1
 ;;^UTILITY(U,$J,358.3,16922,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16922,1,2,0)
 ;;=2^H0004
 ;;^UTILITY(U,$J,358.3,16922,1,3,0)
 ;;=3^Ind Counseling, per 15 min
 ;;^UTILITY(U,$J,358.3,16923,0)
 ;;=H0046^^100^916^14^^^^1
 ;;^UTILITY(U,$J,358.3,16923,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16923,1,2,0)
 ;;=2^H0046
 ;;^UTILITY(U,$J,358.3,16923,1,3,0)
 ;;=3^PTSD Group
 ;;^UTILITY(U,$J,358.3,16924,0)
 ;;=96119^^100^916^11^^^^1
 ;;^UTILITY(U,$J,358.3,16924,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16924,1,2,0)
 ;;=2^96119
 ;;^UTILITY(U,$J,358.3,16924,1,3,0)
 ;;=3^Neuropsych Test by tech,per hr
 ;;^UTILITY(U,$J,358.3,16925,0)
 ;;=96402^^100^916^9^^^^1
 ;;^UTILITY(U,$J,358.3,16925,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16925,1,2,0)
 ;;=2^96402
 ;;^UTILITY(U,$J,358.3,16925,1,3,0)
 ;;=3^Injec,IM,anti-neplastic horm
 ;;^UTILITY(U,$J,358.3,16926,0)
 ;;=96102^^100^916^18^^^^1
 ;;^UTILITY(U,$J,358.3,16926,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16926,1,2,0)
 ;;=2^96102
 ;;^UTILITY(U,$J,358.3,16926,1,3,0)
 ;;=3^Psych Test by Tech,per hr
 ;;^UTILITY(U,$J,358.3,16927,0)
 ;;=96103^^100^916^19^^^^1
 ;;^UTILITY(U,$J,358.3,16927,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16927,1,2,0)
 ;;=2^96103
 ;;^UTILITY(U,$J,358.3,16927,1,3,0)
 ;;=3^Psych Test by computer
 ;;^UTILITY(U,$J,358.3,16928,0)
 ;;=96120^^100^916^12^^^^1
 ;;^UTILITY(U,$J,358.3,16928,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16928,1,2,0)
 ;;=2^96120
 ;;^UTILITY(U,$J,358.3,16928,1,3,0)
 ;;=3^Neuropsych Tst Admin w/Comp
 ;;^UTILITY(U,$J,358.3,16929,0)
 ;;=96125^^100^916^23^^^^1
 ;;^UTILITY(U,$J,358.3,16929,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16929,1,2,0)
 ;;=2^96125
 ;;^UTILITY(U,$J,358.3,16929,1,3,0)
 ;;=3^Stan Cog Perf Tst, per hr
 ;;^UTILITY(U,$J,358.3,16930,0)
 ;;=96372^^100^916^25^^^^1
 ;;^UTILITY(U,$J,358.3,16930,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16930,1,2,0)
 ;;=2^96372
 ;;^UTILITY(U,$J,358.3,16930,1,3,0)
 ;;=3^Ther/Proph/Diag Inj,SC/IM
 ;;^UTILITY(U,$J,358.3,16931,0)
 ;;=Q3014^^100^916^24^^^^1
 ;;^UTILITY(U,$J,358.3,16931,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16931,1,2,0)
 ;;=2^Q3014
 ;;^UTILITY(U,$J,358.3,16931,1,3,0)
 ;;=3^Telehealth Facility Fee
 ;;^UTILITY(U,$J,358.3,16932,0)
 ;;=90887^^100^916^4^^^^1
 ;;^UTILITY(U,$J,358.3,16932,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16932,1,2,0)
 ;;=2^90887
 ;;^UTILITY(U,$J,358.3,16932,1,3,0)
 ;;=3^Consultation w/Family
 ;;^UTILITY(U,$J,358.3,16933,0)
 ;;=90885^^100^916^17^^^^1
 ;;^UTILITY(U,$J,358.3,16933,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16933,1,2,0)
 ;;=2^90885
 ;;^UTILITY(U,$J,358.3,16933,1,3,0)
 ;;=3^Psych Eval of Records
 ;;^UTILITY(U,$J,358.3,16934,0)
 ;;=90889^^100^916^15^^^^1
 ;;^UTILITY(U,$J,358.3,16934,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16934,1,2,0)
 ;;=2^90889
 ;;^UTILITY(U,$J,358.3,16934,1,3,0)
 ;;=3^Preparation of Report
 ;;^UTILITY(U,$J,358.3,16935,0)
 ;;=96118^^100^916^13^^^^1
 ;;^UTILITY(U,$J,358.3,16935,1,0)
 ;;=^358.31IA^3^2
